Related Experiment Video
Updated: Jul 16, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
New Cardiac Glycosides from Digitalis lanata
1Institut für Pharmazeutische Biologie der Philipps-Universität Marburg/Lahn, D-3550 Marburg.
Two novel cardenolides were isolated from Digitalis lanata leaves. These compounds, Digoxigenin-3-O-beta-D-digitoxosido-beta-D-digitoxosido-beta-D-2,6-dideoxy-glucoside and Glucodigoxoside, were structurally identified using chromatographic and spectroscopic techniques.
Area of Science:
- Phytochemistry
- Natural Product Chemistry
- Pharmacognosy
Background:
- Digitalis lanata Ehrh. is a plant species known for its medicinal properties.
- Cardenolides are a class of cardiac glycosides with significant pharmacological activity.
- The ongoing search for novel bioactive compounds from natural sources is crucial for drug discovery.
Purpose of the Study:
- To isolate and structurally elucidate new cardenolide compounds from Digitalis lanata leaves.
- To contribute to the understanding of the chemical constituents of Digitalis lanata.
- To identify potential new leads for therapeutic applications.
Main Methods:
- Thin-layer chromatography (TLC) for compound separation.
- Spectroscopic methods (e.g., NMR, Mass Spectrometry) for structural determination.
- Isolation of bioactive natural products from plant extracts.
Main Results:
- Two previously undescribed cardenolides were successfully isolated from Digitalis lanata.
- The chemical structures were elucidated as Digoxigenin-3-O-beta-D-digitoxosido-beta-D-digitoxosido-beta-D-2,6-dideoxy-glucoside and Glucodigoxoside.
- The study confirmed the presence of complex glycosylated cardenolides in the plant.
Conclusions:
- The phytochemical investigation of Digitalis lanata yielded two new cardenolides.
- The structural elucidation provides valuable data for natural product chemistry.
- These findings may offer new avenues for the development of cardiotonic agents or other pharmaceuticals.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...